OrbiMed, HSG Back Proviva’s Cancer Therapy Platform
02 Dec 2025
US$ 20.00
OrbiMed Advisors LLC has led the over US$30 m series A+ funding round of Proviva Therapeutics (Proviva), with ......
Related Publications
WestBridge Capital has led a US$15 m funding round in Finfactor Technology Pvt Ltd, the parent company of account ......
SMBC Venture Capital and MLC Ventures, the corporate venture arm of Mitsubishi Logistics Corp, were party to the ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.